Wainstok de Calmanovici R, Billi S C, Aldonatti C A, San Martín de Viale L C
Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
Acta Physiol Pharmacol Latinoam. 1987;37(4):541-54.
The purpose of the present work is to investigate the ability of desferrioxamine (DF) as an iron chelator to revert or decrease a severe experimental porphyria induced by hexachlorobenzene (HCB) in rats; DF treatment started after 17 weeks of HCB intoxication and was continued until the 27th week. The urinary excretions of -aminolevulinic acid (ALA), porphobilinogen and porphyrins were weekly quantitated. At the end of the experiment the animals were sacrificed and hepatic porphyrins, ALA-synthase and porphyrinogen carboxy-lyase activities were determined. The results obtained indicated that, under the present conditions, the administered iron chelator does not improve the disturbance promoted by HCB on the haem pathway. These results were compared with those obtained when the DF was given simultaneously with HCB from the beginning of fungicide administration. In this last situation the chelator was able to delay and diminish the porphyrinogenic effect of HCB.
本研究的目的是探讨去铁胺(DF)作为一种铁螯合剂,逆转或减轻大鼠六氯苯(HCB)诱导的严重实验性卟啉症的能力;DF治疗在HCB中毒17周后开始,并持续至第27周。每周定量测定尿中δ-氨基乙酰丙酸(ALA)、胆色素原和卟啉的排泄量。实验结束时处死动物,测定肝脏卟啉、ALA合酶和卟啉原羧基裂解酶活性。所得结果表明,在目前条件下,给予的铁螯合剂不能改善HCB对血红素途径的干扰。将这些结果与从开始施用杀真菌剂起就将DF与HCB同时给予时获得的结果进行了比较。在后一种情况下,螯合剂能够延迟并减轻HCB的卟啉生成作用。